Loading...
Loading...
Browse all stories on DeepNewz
VisitFDA Authorizes Updated Novavax COVID-19 Vaccine for Ages 12 and Older
Aug 30, 2024, 06:43 PM
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for an updated Novavax COVID-19 vaccine. This vaccine is authorized for individuals aged 12 years and older. The updated vaccine is designed to more closely target currently circulating variants, aiming to provide better protection against serious outcomes of COVID-19, such as hospitalization and death. This authorization offers an alternative to mRNA vaccines, expanding the options available for COVID-19 vaccination.
View original story
Markets
Yes • 50%
No • 50%
CDC vaccination data reports
No • 50%
Yes • 50%
CDC vaccination data reports
No • 50%
Yes • 50%
FDA announcements
10 million to 15 million • 25%
More than 15 million • 25%
Less than 5 million • 25%
5 million to 10 million • 25%
CDC vaccination data reports
20 to 30 states • 25%
Less than 10 states • 25%
More than 30 states • 25%
10 to 20 states • 25%
State health department reports and CDC data
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
CDC vaccination data reports